Ann Dermatol.  2014 Oct;26(5):670-673. 10.5021/ad.2014.26.5.670.

Upregulated Expression of Calcyclin-Binding Protein/Siah-1 Interacting Protein in Malignant Melanoma

• Zhu L
• Miake S
• Ijichi A
• Kawahara S
• Kohno M
• Sonoyama H
• Mitamura Y
• Kaku Y
• Tsuru H
• Tu Y
• Furue M

• KMID: 2265523
• DOI: http://doi.org/10.5021/ad.2014.26.5.670

Abstract

No abstract available.

MeSH Terms

Melanoma*

Figure

• 

  Fig. 1 Expression of calcyclin-binding protein/Siah-1 interacting protein in (A) normal skin; sebaceous and glands were depicted in the box, (B) benign melanocytic nevus, (C) primary malignant melanoma (MM), and (D) metastatic MM. Scale bar=100 µm.

Reference

1. Filipek A, Kuźnicki J. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J Neurochem. 1998; 70:1793–1798.

2. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell. 2001; 7:915–926.

3. Wang N, Ma Q, Wang Y, Ma G, Zhai H. CacyBP/SIP expression is involved in the clinical progression of breast cancer. World J Surg. 2010; 34:2545–2552.

4. Chen X, Han G, Zhai H, Zhang F, Wang J, Li X, et al. Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology. 2008; 8:470–477.

5. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem. 2002; 277:28848–28852.

6. Brinck U, Gabius HJ, Zeng FY, Gerke V, Lazarou D, Zografakis C, et al. Differential expression of calcyclin and its accessible ligands in various types of cutaneous tumors. J Dermatol Sci. 1995; 10:181–190.

7. Weterman MA, van Muijen GN, Bloemers HP, Ruiter DJ. Expression of calcyclin in human melanocytic lesions. Cancer Res. 1993; 53:6061–6066.

8. Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer. 1997; 74:464–469.

9. Zhu L, Okano S, Takahara M, Chiba T, Tu Y, Oda Y, et al. Expression of S100 protein family members in normal skin and sweat gland tumors. J Dermatol Sci. 2013; 70:211–219.

10. Zhu L, Kohda F, Nakahara T, Chiba T, Tsuji G, Hachisuka J, et al. Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis. J Dermatol Sci. 2013; 72:311–319.